NUZYRA® is an FDA-approved tetracycline-class antibiotic designed to address a significant unmet need for adult patients with CABP and ABSSSI caused by susceptible bacteria.
Taking on the Challenge of Antimicrobial Resistance (AMR)
AMR is a deadly health threat that according to recent estimates takes the lives of 160,000 Americans each year. It is an ongoing pandemic that will worsen unless we are able to provide new technologies to defeat superbugs.
Taking on the Challenge of Antimicrobial Resistance (AMR)
AMR is a deadly health threat that according to recent estimates takes the lives of 160,000 Americans each year. It is an ongoing pandemic that will worsen unless we are able to provide new technologies to defeat superbugs.
